Bottom line
IDEV vs GSIE: the short answer
IDEV (iShares Core MSCI International Developed Markets ETF) and GSIE (Goldman Sachs ActiveBeta(R) International Equity ETF) share a meaningful slice of their top holdings — about 62% by weight.
But IDEV is far broader, holding 2,337 positions to 660 for GSIE, so beyond the top names it adds exposure GSIE doesn't have.
IDEV is cheaper at 0.04% vs 0.25% — a difference of $21 a year per $10,000 invested.
Over five years, IDEV returned +5.0% a year vs +4.8% for GSIE.
Updated Nov 19, 2026
IDEV vs GSIE side by side
| IDEV | GSIE | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | Goldman Sachs |
| Category | International Stock | International Stock |
| Expense ratio | 0.04% | 0.25% |
| Annual cost per $10k | $4 | $25 |
| 10-yr cost on $10k (prospectus) | $51 | $318 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +4.5% | +5.2% |
| 5-yr return (annualized) | +5.0% | +4.8% |
| 10-yr return (annualized) | — | — |
| Best quarter | +16.9% | +16.0% |
| Worst quarter | −24.0% | −23.1% |
| Net assets (fund) | $31.6B | $5.8B |
| Number of holdings | 2,337 | 660 |
| Portfolio turnover | 3% | 22% |
| Returns as of | Dec 31, 2024 | Dec 31, 2024 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IDEV | GSIE | Difference |
|---|---|---|---|
| 2024 | +4.5% | +5.2% | −0.7% |
| 2023 | +17.3% | +17.3% | +0.0% |
| 2022 | −14.9% | −15.9% | +1.0% |
| 2021 | +12.7% | +13.1% | −0.3% |
| 2020 | +8.4% | +8.0% | +0.4% |
| 2019 | +23.4% | +22.2% | +1.2% |
| 2018 | −14.3% | −12.9% | −1.4% |
Source: Fund prospectus bar charts
Holdings overlap
14 of IDEV's top 25 holdings also appear in GSIE's top 25.
| Holding | IDEV | GSIE |
|---|---|---|
| ASML Holding N.V. | 2.19% | 2.11% |
| Hsbc Holdings Plc | 1.24% | 1.06% |
| Roche Holding AG | 1.05% | 1.01% |
| Royal Bank Of Canada | 1.00% | 1.06% |
| Novartis AG | 0.98% | 1.02% |
| Astrazeneca Plc | 0.88% | 0.88% |
| Shell Plc | 0.88% | 0.61% |
| Mitsubishi UFJ Financial Group, Inc. | 0.82% | 0.48% |
| Banco Santander, S.A. | 0.70% | 0.80% |
| The Toronto-dominion Bank | 0.68% | 0.78% |
| Sap Se | 0.65% | 0.48% |
| Allianz SE | 0.65% | 0.57% |
| Totalenergies Se | 0.59% | 0.46% |
| Banco Bilbao Vizcaya Argentaria, S.A. | 0.54% | 0.55% |
Source: SEC Form N-PORT
IDEV top 10
- ASML Holding N.V. — 2.19%
- Hsbc Holdings Plc — 1.24%
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 1.16%
- Roche Holding AG — 1.05%
- Royal Bank Of Canada — 1.00%
- Novartis AG — 0.98%
- Astrazeneca Plc — 0.88%
- Nestle S.A. — 0.88%
- Shell Plc — 0.88%
- Siemens Aktiengesellschaft — 0.83%
GSIE top 10
- Goldman Sachs Financial Square Funds Prime Obligations Fund — 3.82%
- Asml Holding Nv — 2.11%
- Goldman Sachs Trust — 1.07%
- Hsbc Holdings Plc — 1.06%
- Royal Bank Of Canada — 1.06%
- Novartis Ag — 1.02%
- Roche Holding Ag — 1.01%
- Astrazeneca Plc — 0.88%
- Banco Santander Sa — 0.80%
- Toronto Dominion Bank (the) — 0.78%
FAQ
What is the difference between IDEV and GSIE?
Which is cheaper, IDEV or GSIE?
Should I own both IDEV and GSIE?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.